Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangrong Yan

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Journal of Biopharmaceutical Statistics|April 14, 2024
Adaptive promising zone design for cancer immunotherapy with heterogeneous delayed treatment effectBosheng Li, Fangrong Yan, Depeng Jiang
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|April 25, 2022
An Adaptive Information Borrowing Platform Design for Testing Drug Candidates of COVID-19Liwen Su, Jingyi Zhang, Fangrong Yan
The New England Journal of Medicine|May 9, 2019
One-Year Outcomes after PCI Strategies in Cardiogenic ShockFangrong Yan, Peter Thall, Ying Yuan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2017
Keyboard: A Novel Bayesian Toxicity Probability Interval Design for Phase I Clinical TrialsFangrong Yan, Sumithra J Mandrekar, Ying Yuan
Contemporary Clinical Trials|June 7, 2021
Optimal Bayesian hierarchical model to accelerate the development of tissue-agnostic drugs and basket trialsLiyun Jiang, Lei Nie, Fangrong Yan, et al.
BMC Medical Research Methodology|March 21, 2023
IBIS: identify biomarker-based subgroups with a Bayesian enrichment design for targeted combination therapyXin Chen, Jingyi Zhang, Liyun Jiang, et al.
Pharmaceutical Statistics|May 8, 2023
A comparative study of adaptive trial designs for dose optimizationJingyi Zhang, Xin Chen, Bosheng Li, et al.
Journal of Immunotherapy and Precision Oncology|September 2, 2024
MC-Keyboard: A Practical Phase I Trial Design for Targeted Therapies and Immunotherapies Integrating Multiple-Grade ToxicitiesLiyun Jiang, Zhulin Yin, Fangrong Yan, et al.
BMC Medical Research Methodology|November 8, 2024
Determining doses for backfill cohorts based on patient-reported outcomeXin Chen, Jingyi Zhang, Bosheng Li, et al.
Statistical Methods in Medical Research|October 11, 2022
Shotgun-2: A Bayesian phase I/II basket trial design to identify indication-specific optimal biological dosesXin Chen, Jingyi Zhang, Liyun Jiang, et al.
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Journal of Biopharmaceutical Statistics|April 14, 2024
Adaptive promising zone design for cancer immunotherapy with heterogeneous delayed treatment effectBosheng Li, Fangrong Yan, Depeng Jiang
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|April 25, 2022
An Adaptive Information Borrowing Platform Design for Testing Drug Candidates of COVID-19Liwen Su, Jingyi Zhang, Fangrong Yan
The New England Journal of Medicine|May 9, 2019
One-Year Outcomes after PCI Strategies in Cardiogenic ShockFangrong Yan, Peter Thall, Ying Yuan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2017
Keyboard: A Novel Bayesian Toxicity Probability Interval Design for Phase I Clinical TrialsFangrong Yan, Sumithra J Mandrekar, Ying Yuan
Contemporary Clinical Trials|June 7, 2021
Optimal Bayesian hierarchical model to accelerate the development of tissue-agnostic drugs and basket trialsLiyun Jiang, Lei Nie, Fangrong Yan, et al.
BMC Medical Research Methodology|March 21, 2023
IBIS: identify biomarker-based subgroups with a Bayesian enrichment design for targeted combination therapyXin Chen, Jingyi Zhang, Liyun Jiang, et al.
Pharmaceutical Statistics|May 8, 2023
A comparative study of adaptive trial designs for dose optimizationJingyi Zhang, Xin Chen, Bosheng Li, et al.
Journal of Immunotherapy and Precision Oncology|September 2, 2024
MC-Keyboard: A Practical Phase I Trial Design for Targeted Therapies and Immunotherapies Integrating Multiple-Grade ToxicitiesLiyun Jiang, Zhulin Yin, Fangrong Yan, et al.
BMC Medical Research Methodology|November 8, 2024
Determining doses for backfill cohorts based on patient-reported outcomeXin Chen, Jingyi Zhang, Bosheng Li, et al.
Statistical Methods in Medical Research|October 11, 2022
Shotgun-2: A Bayesian phase I/II basket trial design to identify indication-specific optimal biological dosesXin Chen, Jingyi Zhang, Liyun Jiang, et al.
Pageof 13